Miostat (Carbachol)

Carbachol, the active ingredient in Miostat, is a cholinergic agonist presented as a sterile ophthalmic solution for intraocular use. It is employed to lower intraocular pressure in glaucoma and to induce miosis during intraocular surgery. GNH USA supplies Miostat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbachol acts on the ocular muscarinic pathway to manage pressure‑related and surgical eye conditions. - Glaucoma: reduces intraocular pressure by increasing aqueous humor outflow. - Intraocular surgery: induces miosis to improve surgical visualization and control. - Ocular hypertension: helps lower elevated eye pressure in patients at risk of glaucoma.

Carbachol may cause ocular and systemic reactions that vary in frequency.

Common Side Effects: - Blurred vision: transient loss of visual clarity after administration. - Eye pain or discomfort: mild irritation at the instillation site. - Conjunctival redness: mild hyperemia of the eye. - Increased lacrimation: excess tearing. - Headache: mild to moderate headache following dosing. - Transient visual disturbances: temporary halos or glare.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or anaphylaxis. - Persistent miosis: prolonged pupil constriction affecting vision. - Corneal edema: swelling of the cornea leading to visual impairment. - Systemic cholinergic effects: bradycardia, bronchospasm, or hypotension. - Hypotony: abnormally low intraocular pressure. - Endophthalmitis: intraocular infection (rare).

Before using Carbachol, consider the following safety measures. - Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown excretion; use with caution. - Narrow‑angle glaucoma: contraindicated due to risk of angle closure. - Respiratory disease: use cautiously in asthma or COPD as cholinergic effects may exacerbate bronchospasm. - Cardiovascular disease: monitor patients with bradycardia or heart block for systemic effects. - Store at room temperature: keep in original container, protect from light and moisture.

Carbachol can interact with other medications affecting cholinergic pathways or ocular physiology.

Major Interactions (Avoid): - Systemic anticholinergics: may diminish Carbachol's ocular effect. - Cholinesterase inhibitors: can potentiate ocular cholinergic activity, increasing risk of miosis. - Other miotics (e.g., pilocarpine): additive pupil constriction may lead to excessive miosis. - Systemic cholinergic agents: heightened systemic side effects such as bradycardia.

Moderate Interactions (Monitor Closely): - Topical NSAIDs: may increase ocular irritation when used together. - Corticosteroid eye drops: could mask inflammatory signs while Carbachol is administered. - Systemic beta‑agonists: may counteract intraocular pressure‑lowering effect.